Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-004961-25Phase 3Active
Phase 3, randomised trial of ketamine in traumatic limb pain, Extremity Injuries and Acute traumatic pain (2 arms), sponsored by CHU de Lille. Primary endpoint: Morphine consumption reduction at 60 minutes. Started Oct 2008; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-004961-25.